drugset / Trial / NCT02368249

Does Terlipressin Improve Renal Outcome After Liver Surgery

NCT02368249

Phase 2 Withdrawn University of Zurich
RandomizedSingle-groupDouble-blindPrevention

Summary

The investigators aim to address whether terlipressin improves the renal outcome after liver surgery. Therefore the investigators are planning to conduct a double-blinded randomized control trial. The investigators will randomize patients undergoing any kind of liver surgery and being at increased moderate to high risk for post-operative acute renal failure into a control group receiving post- operative a placebo or into a group receiving post-operatively terlipressin in combination with human albumin.

Timeline

Start
2020-01
Primary completion
2025-02
Completion
2025-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide Intravenous

Indications